3
Announcements
Trials
Browse
Landscape
Status
Unknown
1
Sponsor Class
OTHER_GOV
1
Study Type
Observational
1
Sponsor
Cancer Type
Head & Neck
1
Endocrine
1
Conditions
Neuroendocrine Tumors
2
Multiple Endocrine Neoplasia Type 1
2
Thyroid Carcinoma, Anaplastic
1
Thyroid Cancer, Papillary
1
Thymus Neoplasms
1
Pituitary Neoplasms
1
Pheochromocytoma
1
Parathyroid Diseases
1
Paraganglioma
1
Pancreatic Neoplasms
1
Obesity
1
Midgut Neuroendocrine Tumors
1
High Grade Neuroendocrine Neoplasms
1
Brain Neoplasms
1
Atherosclerosis
1
Adrenocortical Carcinoma
1
Interventions
Paclitaxel
10
trametinib
9
dabrafenib
9
pembrolizumab
5
lenvatinib
5
fosbretabulin
4
Sorafenib
4
Radiotherapy, Intensity-Modulated
4
Doxorubicin
4
Radiotherapy
3
Cisplatin
3
pazopanib
2
efatutazone
2
combretastatin
2
cobimetinib
2
cemiplimab
2
atezolizumab
2
aldesleukin
2
Vemurafenib
2
Trastuzumab
2
Taxes
2
Nivolumab
2
Gefitinib
2
Filgrastim
2
Everolimus
2
Docetaxel
2
Carboplatin
2
Bevacizumab
2
zimberelimab
1
vandetanib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Thyroid Carcinoma, Anaplastic
×
Blood Specimen Collection
×
Endocrine
×
Clear all
NCT01774279
2021-01-05
iNATT
Velindre NHS Trust
Unknown
350 enrolled